Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Pentacarinat
|
| gptkbp:activities |
inhibits parasite growth
|
| gptkbp:appointed_by |
oral medication
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:can_be_used_with |
gptkb:lumefantrine
|
| gptkbp:clinical_trial |
approximately 30%
|
| gptkbp:developed_by |
gptkb:artemisinin
gptkb:Novartis |
| https://www.w3.org/2000/01/rdf-schema#label |
artemether
|
| gptkbp:ingredients |
C17 H26 O5
|
| gptkbp:is_atype_of |
P01 B F01
|
| gptkbp:is_used_for |
treatment of malaria
|
| gptkbp:marketed_as |
gptkb:Coartem
|
| gptkbp:side_effect |
dizziness
headache nausea vomiting |
| gptkbp:type_of |
71963-77-4
|